MedPath

Clinical response of recurrence risk and the SGLT2 inhibitor of the ischemic heart disease

Not Applicable
Conditions
the patients of ischemic heart disease and type2 DM who performed elective percutaneous coronary intervention
Registration Number
JPRN-UMIN000023103
Lead Sponsor
Mito Kyodo General Hospital , Tsukuba University Hospital Mito Clinical Education and Training Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1)hemodyaliysis (2)eGFR<30ml/min/1.73m2 (3)possibility of the dehydration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath